Reproductive choices for genetic skin conditions
Part of Bones, joints & muscles, Brain & nervous system, Cancer, Eyes & vision, Genetic & congenital, Hormones & metabolism, Mouth & dental, Skin clinical trials.
This study looks at the choices families have when they carry a genetic skin condition. It aims to learn more about how prenatal testing and IVF with genetic testing can help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your partner have a confirmed genetic skin condition (like a disorder of skin shedding, blistering, growth, or skin cancer risk).
- You have already had prenatal testing during pregnancy or used IVF with genetic testing of embryos.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study interviews people with inherited skin conditions (genodermatoses) who want to have children, and the doctors who care for them. The goal is to learn how to better support family planning decisions, like counseling about genetics and pregnancy risks.
This study tests a medication called deucravacitinib for adults with rare genetic skin conditions that cause blisters or severe scaling. The goal is to see if it can reduce symptoms safely.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This study (a “cohort”) follows people with certain rare skin conditions over time. It helps doctors better understand these diseases and improve long-term care, and you may be asked to complete surveys.
This trial builds lab tests using a patient’s own skin cells to see whether the disease’s underlying gene problem can be shown in the lab. If you have a rare inherited (genetic) disease with no good treatment, this could help researchers find clearer, functional ways to measure the disease and test future therapies.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.